Printer Friendly

DR. SHARON HENRY OF BRISTOL-MYERS SQUIBB COMPANY RECEIVES HEALTH WATCH'S FIRST WOMEN'S LEADERSHIP AWARD

 PRINCETON, N.J., April 27 /PRNewswire/ -- Sharon A. Henry, M.D., vice president of medical operations for Bristol-Myers Squibb Company (NYSE: BMY) U.S. Pharmaceutical Division, will be presented with the first Women's Leadership Award, sponsored by Health Watch at its annual awards gala to be held at 8 p.m., Wednesday, April 28, at the Starlight Roof of the Waldorf Astoria.
 Health Watch will honor Henry for her "foresight, capability and skill in assuming a position of responsibility and leadership in the pharmaceutical industry and, in doing so, setting an example as a minority woman of accomplishment in the health industry, thus furthering the cause of minority health," explained Norma J. Goodwin, M.D., president of Health Watch.
 "I am very honored to be recognized by Health Watch as a leader among my peers," said Henry. "I applaud the fine work of this organization in promoting healthy lifestyles and disease prevention in the minority community."
 Established in 1984, Health Watch is a national not-for-profit New York-based health information and promotion corporation whose sole mission is to improve the health and longevity of African-Americans and other minority populations through education and disease control.
 "We are extremely proud of Dr. Henry, whose contributions have been instrumental in the significant expansion of medical support and clinical research operations for the company," said Sam Barker, Ph.D., president, Bristol-Myers Squibb Company U.S. Pharmaceutical Division.
 Henry joined Bristol-Myers Squibb Company in 1982 as an assistant director of clinical research, anti-infectives. Subsequently, she held medical research positions of increasing responsibility, including medical director of medical development and, later, medical marketing, E.R. Squibb & Sons. More recently, Henry was promoted to vice president, medical operations, Bristol-Myers Squibb Company, U.S. Pharmaceutical Division.
 A licensed physician in New York and New Jersey, Henry received both her B.A. and doctorate in medicine from New York University in 1972 and 1976 respectively. She interned at NYU Medical Center Bellevue and the New York Department of Veteran's Affairs Medical Center and completed subspecialty training in infectious diseases at Boston University, Boston City and Memorial Sloan Kettering hospitals. She has held teaching positions at both Memorial Sloan Kettering and the New York Hospital, Cornell University.
 Bristol-Myers Squibb Company is a diversified healthcare company whose principal businesses are pharmaceuticals, nutritionals, consumer products and medical devices. It is among the world's leading makers of cardiovascular, anticancer, anti-infective, central nervous system and dermatological drug therapies and diagnostic agents.
 /delval/
 -0- 4/27/93
 /CONTACT: Patrick Donohue of Bristol-Myers Squibb Co., 609-252-5685, or Matthew Zinman of Harris, Baio and McCullough, 215-440-9800, for Bristol-Myers Squibb/


CO: Bristol-Myers Squibb Co.; Health Watch ST: New Jersey IN: SU:

CC-MJ -- PH001 -- 1087 04/27/93 07:02 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Apr 27, 1993
Words:451
Previous Article:HIGH TECH CAMERAS AND LOUSY PICTURES; CAPTURE THE CHILD WITH 'CREATIVE TECHNIQUES FOR PHOTOGRAPHING CHILDREN,' TIPS ON TAKING TIMELESS PHOTOGRAPHS OF...
Next Article:BALLOT RESULTS INDICATE STRONG SUPPORT FOR WIDEBAND CDMA DIGITAL CELLULAR INDUSTRY STANDARD
Topics:


Related Articles
BRISTOL-MYERS SQUIBB EXECUTIVE JOAN K. KEITH TO BE HONORED APRIL 7 AS HEALTHCARE BUSINESSWOMEN'S ASSOCIATION WOMAN OF THE YEAR
BRISTOL-MYERS SQUIBB LAUNCHES 'KIDNEYWATCH'; MAJOR AWARENESS CAMPAIGN TARGETS CONSUMERS ABOUT DIABETES-RELATED KIDNEY DISEASE
DR. SOL I. RAJFER APPOINTED TO BRISTOL-MYERS SQUIBB SR. VICE PRESIDENT WORLDWIDE CLINICAL R&D
Pierre Le Sourd , M.D., to be Named President of UPSA Laboratories
Dyax Corp. Names Peter Sprague Vice President of Drug Discovery, Research Division
Bristol-Myers Squibb and the Government of South Africa Announce Partnership to Address HIV/AIDS.
Beth C. Seidenberg, M.D., Appointed Senior Vice President, Clinical Development and Life Cycle Management at Bristol-Myers Squibb Company.
Bristol-Myers Squibb is Honored for its Diversity Efforts by The Long Island Hispanic Business Community.
Bristol-Myers Squibb Names R. Sanders Williams, M.D. to Board of Directors.
Bristol-Myers Squibb Company Announces Promotion of Andrew Bonfield and Elliott Sigal to Executive Vice Presidents.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters